GTS Securities’s Fusion Pharmaceuticals Inc. Common Shares FUSN Stock Holding History

GTS Securities’s Portfolio FUSN Stock Details FUSN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-11,400	Closed	-$243K	–	4437
2024 Q1	$243K	Buy	+11,400	New	+$136K	﹤0.01%	3180

GTS Securities's FUSN Position: Q2 2024 in Review

GTS Securities sold out of Fusion Pharmaceuticals Inc. Common Shares (FUSN) in Q2 2024, closing a stake of 29,095 shares — an estimated $620K sold.

GTS Securities first reported a position in FUSN in Q1 2024 and held it in 1 quarter. The position peaked at $620K in Q1 2024. 0 funds tracked by Wall St. Rank hold FUSN as of Q2 2024.

GTS Securities reported no remaining Fusion Pharmaceuticals Inc. Common Shares position as of Q2 2024 after selling out during the quarter.
GTS Securities sold 29,095 Fusion Pharmaceuticals Inc. Common Shares shares in Q2 2024, an estimated $620K.
GTS Securities first reported a position in Fusion Pharmaceuticals Inc. Common Shares in Q1 2024 and held it in 1 quarter.
GTS Securities's Fusion Pharmaceuticals Inc. Common Shares position peaked at $620K in Q1 2024.
0 funds tracked by Wall St. Rank held Fusion Pharmaceuticals Inc. Common Shares as of Q2 2024.

Based on GTS Securities's 13F filing for Q2 2024, filed 14 Aug 2024.